|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 197.80 USD | -0.56% |
|
-5.01% | +12.52% |
| 09/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 29.37B 25.69B 23.69B 21.92B 41.6B 2,803B 42.3B 284B 111B 1,377B 110B 108B 4,768B | P/E 2026 * |
30.3x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 34.88B 30.51B 28.13B 26.03B 49.41B 3,329B 50.23B 337B 132B 1,635B 131B 128B 5,662B | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.56% | ||
| 1 week | -5.01% | ||
| Current month | -8.35% | ||
| 1 month | +1.95% | ||
| 3 months | +14.48% | ||
| 6 months | +6.67% | ||
| Current year | +12.52% |
| 1 week | 194.37 |  | 215.95 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.68 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | -5.01% | +46.32% | -29.68% | 29.37B | |
| -0.89% | +1.91% | +18.31% | -5.85% | 67.96B | |
| -5.16% | -8.63% | +37.37% | +202.27% | 54.4B | |
| -2.10% | +4.37% | -49.58% | -53.96% | 41.74B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 40.63B | |
| -10.61% | -16.05% | +100.32% | -44.21% | 30.38B | |
| -2.09% | +0.16% | +64.64% | +87.12% | 23.68B | |
| +3.88% | +5.10% | +9.06% | +196.53% | 19.15B | |
| -3.49% | +12.04% | +88.26% | +401.79% | 17.68B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 17.14B | |
| Average | -1.75% | +1.14% | +41.53% | +92.43% | 34.21B | |
| Weighted average by Cap. | -1.82% | +0.36% | +33.71% | +66.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.05B 8.8B 8.11B 7.5B 14.24B 960B 14.48B 97.13B 38.08B 471B 37.74B 36.93B 1,632B | 10.38B 9.08B 8.38B 7.75B 14.71B 991B 14.96B 100B 39.33B 487B 38.98B 38.14B 1,686B |
| Net income | 1.49B 1.31B 1.21B 1.12B 2.12B 143B 2.15B 14.44B 5.66B 70.07B 5.61B 5.49B 243B | 1.97B 1.72B 1.59B 1.47B 2.79B 188B 2.84B 19.02B 7.46B 92.29B 7.39B 7.23B 320B |
| Net Debt | 5.51B 4.82B 4.44B 4.11B 7.8B 526B 7.93B 53.22B 20.86B 258B 20.68B 20.23B 894B | 3.38B 2.96B 2.73B 2.53B 4.8B 323B 4.88B 32.7B 12.82B 159B 12.71B 12.43B 550B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/26 | USD 198.13 | -0.39% | 281,600 |
| 09/07/26 | USD 198.91 | -0.72% | 1,657,327 |
| 08/07/26 | USD 200.36 | -2.60% | 1,947,888 |
| 07/07/26 | USD 205.70 | -1.32% | 1,156,880 |
| 06/07/26 | USD 208.46 | -3.54% | 1,218,492 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
